AGIOS PHARMACEUTICALS, INC. (AGIO) › Net IncomeAGIOS PHARMACEUTICALS, INC. (AGIO) — Net IncomeAnnual figures by fiscal year, from SEC filings.2011: -$23.71M2012: -$20.10M2013: -$39.41M2014: -$53.50M2015: -$117.73M2016: -$198.47M2017: -$314.67M2018: -$346.03M2019: -$411.47M2020: -$327.37M2021: $1.60B2022: -$231.80M2023: -$352.09M2024: $673.73M2025: -$412.78M-$412.78M2011Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$412.78M-161.3%2024$673.73M+291.4%2023-$352.09M-51.9%2022-$231.80M-114.4%2021$1.60B+590.2%2020-$327.37M+20.4%2019-$411.47M-18.9%2018-$346.03M-10.0%2017-$314.67M-58.5%2016-$198.47M-68.6%2015-$117.73M-120.0%2014-$53.50M-35.8%2013-$39.41M-96.0%2012-$20.10M+15.2%2011-$23.71M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share